The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg downgrades Biffa, raises Kosmos

Thu, 25th Aug 2022 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Investec cuts Aveva to 'hold' ('buy') - target 2,700 pence

----------

Jefferies raises Centrica price target to 90 (72) pence - 'hold'

----------

JPMorgan raises Rentokil Initial price target to 650 (600) pence - 'overweight'

----------

FTSE 250

----------

UBS raises FirstGroup price target to 120 (114) pence - 'neutral'

----------

Liberum raises Centamin price target to 121 (102) pence - 'buy'

----------

Berenberg cuts Marshalls price target to 400 (620) pence - 'hold'

----------

Berenberg cuts Biffa to 'hold' ('buy') - target 415 (465) pence

----------

Jefferies cuts Coats price target to 96 (100) pence - 'buy'

----------

SMALL CAP

----------

RBC starts Digital 9 Infrastructure with 'outperform' - price target 145 pence

----------

Jefferies cuts Severfield price target to 101 (108) pence - 'buy'

----------

Berenberg raises Kosmos Energy to 'buy' ('hold') - target 710 (670) pence

----------

Liberum starts coverage on Open Orphan at 'buy' - 21.6p price target

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
11 May 2020 12:03

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Read more
11 May 2020 09:06

Open Orphan inks contract with Quotient on Covid-19 antibody testing

(Sharecast News) - Pharmaceutical services company Open Orphan's hVIVO subsidiary has entered into an exclusive contract with Quotient to support Covid-19 antibody testing in the UK.

Read more
4 May 2020 16:21

Open Orphan signs ?3.5m deal with US biotech firm

(Sharecast News) - Pharmaceutical services company Open Orphan announced the signing of a new contract with an unnamed US biotechnology company on Monday, for the provision of a respiratory syncytial virus (RSV) human challenge study.

Read more
4 May 2020 14:35

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Open Orphan CEO Steps Down; Inks New Challenge Study Contract

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
23 Apr 2020 10:21

Open Orphan begins testing of Covid-19 anti-viral treatment

(Sharecast News) - Pharmaceutical services company Open Orphan said it had started testing an anti-viral drug to treat Covid-19 on behalf of its client Nearmedic International.

Read more
10 Mar 2020 14:48

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Open Orphan Notes Publication Of FLU-v Vaccine Study In Journal

Read more
9 Mar 2020 14:17

Open Orphan Starts On Coronavirus Challenge Study Model

Open Orphan Starts On Coronavirus Challenge Study Model

Read more
6 Mar 2020 15:23

Open Orphan agrees study with European biotech firm

(Sharecast News) - Orphan drugs-focussed pharmaceutical company Open Orphan announced the signing of a new contract with an unnamed European biotechnology firm for the provision of an RSV human challenge study.

Read more
6 Mar 2020 11:57

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Open Orphan Inks New Virus Study Contract With Potential Follow-On

Read more
27 Feb 2020 17:56

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

EXECUTIVE CHANGE SUMMARY: Burford Capital Adds Independent Directors

Read more
13 Feb 2020 14:45

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Open Orphan Appoints Interim CFO Leo Toole To Permanent Role

Read more
31 Jan 2020 15:39

Open Orphan raising at least ?5m for merger with hVIVO

(Sharecast News) - Pharmaceutical services company Open Orphan announced a fundraising to raise a minimum of £5m before expenses via a conditional placing of new ordinary shares on Friday, at a price of 6.1p each, to institutional and other investors.

Read more
31 Jan 2020 12:39

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Open Orphan Raises GBP5.3 Million To Fund hVIVO Synergy Programme

Read more
23 Jan 2020 18:32

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Open Orphan In Talks With Investors Regarding GBP5 Million Placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.